Literature DB >> 16052696

Apoptosis induction with polo-like kinase-1 antisense phosphorothioate oligodeoxynucleotide of colon cancer cell line SW480.

Yu Fan1, Shu Zheng, Ze-Feng Xu, Jia-Yi Ding.   

Abstract

AIM: To investigate the effects of polo-like kinase-1 (PLK1) antisense phosphorothioate oligodeoxynucleotide (ASODN) on apoptosis and cell cycle of human colon cancer cell line SW480.
METHODS: After SW480 colon cancer cells were transfected with PLK1 ASODN, Northern and Western blot analyses were used to examine PLK1 gene expression in cancer cells. We studied apoptosis using terminal uridine deoxynucleotidyl nick end labeling. Apoptosis and cell cycle of SW480 cells were examined by fluorescence-activated cell sorter scan.
RESULTS: The levels of PLK1 mRNA and protein were greatly inhibited by PLK1 ASODN in SW480 cancer cells transfected with PLK1 ASODN. Apoptosis index (AI) induced PLK1 ASODN in a time- and dose-dependent manner. Results from FLM showed that sub-2N DNA content of transfected cancer cells was significantly increased and arrested at G2/M compared with control groups.
CONCLUSION: PLK1 ASODN can induce apoptosis of human colon cancer cell line SW480.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16052696      PMCID: PMC4398716          DOI: 10.3748/wjg.v11.i29.4596

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  20 in total

Review 1.  Synthetic oligonucleotides: the development of antisense therapeutics.

Authors:  D K Monteith; A A Levin
Journal:  Toxicol Pathol       Date:  1999 Jan-Feb       Impact factor: 1.902

Review 2.  Polo-like kinases: a team that plays throughout mitosis.

Authors:  D M Glover; I M Hagan; A A Tavares
Journal:  Genes Dev       Date:  1998-12-15       Impact factor: 11.361

3.  Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase.

Authors:  F Toyoshima-Morimoto; E Taniguchi; N Shinya; A Iwamatsu; E Nishida
Journal:  Nature       Date:  2001-03-08       Impact factor: 49.962

4.  Expression of polo-like kinase in ovarian cancer is associated with histological grade and clinical stage.

Authors:  N Takai; T Miyazaki; K Fujisawa; K Nasu; R Hamanaka; I Miyakawa
Journal:  Cancer Lett       Date:  2001-03-10       Impact factor: 8.679

5.  Comparative expression of the mitotic regulators SAK and PLK in colorectal cancer.

Authors:  J C Macmillan; J W Hudson; S Bull; J W Dennis; C J Swallow
Journal:  Ann Surg Oncol       Date:  2001-10       Impact factor: 5.344

6.  The conserved Schizosaccharomyces pombe kinase plo1, required to form a bipolar spindle, the actin ring, and septum, can drive septum formation in G1 and G2 cells.

Authors:  H Ohkura; I M Hagan; D M Glover
Journal:  Genes Dev       Date:  1995-05-01       Impact factor: 11.361

7.  Prognostic significance of polo-like kinase (PLK) expression in squamous cell carcinomas of the head and neck.

Authors:  R Knecht; R Elez; M Oechler; C Solbach; C von Ilberg; K Strebhardt
Journal:  Cancer Res       Date:  1999-06-15       Impact factor: 12.701

8.  Polo-like kinase 1 (PLK1) is overexpressed in primary colorectal cancers.

Authors:  Takao Takahashi; Bun Sano; Takayasu Nagata; Hiroki Kato; Yasuyuki Sugiyama; Katsuyuki Kunieda; Masashi Kimura; Yukio Okano; Shigetoyo Saji
Journal:  Cancer Sci       Date:  2003-02       Impact factor: 6.716

9.  Cooperative phosphorylation including the activity of polo-like kinase 1 regulates the subcellular localization of cyclin B1.

Authors:  Juping Yuan; Frank Eckerdt; Jürgen Bereiter-Hahn; Elisabeth Kurunci-Csacsko; Manfred Kaufmann; Klaus Strebhardt
Journal:  Oncogene       Date:  2002-11-28       Impact factor: 9.867

10.  Induction and down-regulation of PLK, a human serine/threonine kinase expressed in proliferating cells and tumors.

Authors:  U Holtrich; G Wolf; A Bräuninger; T Karn; B Böhme; H Rübsamen-Waigmann; K Strebhardt
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

View more
  7 in total

1.  A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment.

Authors:  Galina A Gusarova; I-Ching Wang; Michael L Major; Vladimir V Kalinichenko; Timothy Ackerson; Vladimir Petrovic; Robert H Costa
Journal:  J Clin Invest       Date:  2006-12-14       Impact factor: 14.808

2.  Aberrant Wnt/beta-catenin signaling can induce chromosomal instability in colon cancer.

Authors:  Michel V Hadjihannas; Martina Brückner; Boris Jerchow; Walter Birchmeier; Wolfgang Dietmaier; Jürgen Behrens
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-30       Impact factor: 11.205

Review 3.  Novel translational strategies in colorectal cancer research.

Authors:  Ignacio Gil-Bazo
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

4.  Inhibition of signal transducer and activator of transcription 3 expression by RNA interference suppresses invasion through inducing anoikis in human colon cancer cells.

Authors:  Yu Fan; You-Li Zhang; Ying Wu; Wei Zhang; Yin-Huan Wang; Zhao-Ming Cheng; Hua Li
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

Review 5.  Cross Talk between Wnt/β-Catenin and CIP2A/Plk1 Signaling in Prostate Cancer: Promising Therapeutic Implications.

Authors:  Ion Cristóbal; Federico Rojo; Juan Madoz-Gúrpide; Jesús García-Foncillas
Journal:  Mol Cell Biol       Date:  2016-05-31       Impact factor: 4.272

Review 6.  Regulatory functional territory of PLK-1 and their substrates beyond mitosis.

Authors:  Shiv Kumar; Garima Sharma; Chiranjib Chakraborty; Ashish Ranjan Sharma; Jaebong Kim
Journal:  Oncotarget       Date:  2017-06-06

7.  Synergistic apoptotic effect of miR-183-5p and Polo-Like kinase 1 inhibitor NMS-P937 in breast cancer cells.

Authors:  Masahisa Kudo; Nicole Zalles; Rosario Distefano; Giovanni Nigita; Dario Veneziano; Pierluigi Gasparini; Carlo M Croce
Journal:  Cell Death Differ       Date:  2021-09-24       Impact factor: 12.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.